Literature DB >> 12566953

Incidence of Parkinson's disease in estonia.

Pille Taba1, Toomas Asser.   

Abstract

The incidence of Parkinson's disease (PD) was studied over a 9-year period (1990-1998) in Tartu county, Estonia, with a mean population of 156,417. Based on 264 patients, the average crude incidence rate of PD was 18.8 per 100,000 person-years. The age-adjusted incidence was 16.8/100,000; 18.3 for the urban group and 14.0 for the rural group; 16.6 for men and 17.1 for women. The age-specific incidence was 1.0/100,000 in the age range 30-39 years, reached a maximum of 117.2/100,000 in the age range 70-79 years and declined in the elderly. The incidence of PD was comparable with that found in developed countries, except for a slightly higher (not significant) incidence rate in the urban compared with the rural population in Estonia. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12566953     DOI: 10.1159/000067105

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  4 in total

1.  Heterogeneity in male to female risk for Parkinson's disease.

Authors:  K S M Taylor; J A Cook; C E Counsell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08       Impact factor: 10.154

2.  Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

Authors:  Allison Wright Willis; Bradley A Evanoff; Min Lian; Susan R Criswell; Brad A Racette
Journal:  Neuroepidemiology       Date:  2010-01-15       Impact factor: 3.282

3.  Variations in Incidence and Prevalence of Parkinson's Disease in Taiwan: A Population-Based Nationwide Study.

Authors:  Chih-Ching Liu; Chung-Yi Li; Pei-Chen Lee; Yu Sun
Journal:  Parkinsons Dis       Date:  2016-01-19

4.  Region-Based Analysis of Prevalence and Incidence of Parkinson's Disease: Analysis of the National Sample Cohort in South Korea.

Authors:  Seung Hwan Lee; Seung Joon Lee; Young Ju Kim
Journal:  J Clin Neurol       Date:  2018-06-27       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.